There are no specific answers to these questions on the Glaucus website. IMO It's all very general, and vague.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
BM8 Rising demand, China's 'tech war' bans leaves this germanium explorer with significant investment potential
I88 History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025